tiprankstipranks
Trending News
More News >

Quipt Home Medical Reports Q2 2025 Results Amid Revenue Challenges

Story Highlights

Confident Investing Starts Here:

Quipt Home Medical ( (TSE:QIPT) ) has issued an update.

Quipt Home Medical reported its fiscal second quarter 2025 results, highlighting a 6% decrease in revenue compared to the previous year, primarily due to the loss of a Medicare Advantage agreement and a non-renewed disposable supply contract. Despite these challenges, the company maintained a strong adjusted EBITDA of 23.3% of revenue and launched new initiatives, including two De Novo sites and a Medicare-approved airway clearance device, to enhance its market position and drive future growth. Management remains focused on organic growth and operational efficiency, aiming to deepen partnerships with healthcare systems.

The most recent analyst rating on (TSE:QIPT) stock is a Buy with a C$9.50 price target. To see the full list of analyst forecasts on Quipt Home Medical stock, see the TSE:QIPT Stock Forecast page.

Spark’s Take on TSE:QIPT Stock

According to Spark, TipRanks’ AI Analyst, TSE:QIPT is a Neutral.

Quipt Home Medical shows strong revenue growth and cash flow management, yet faces challenges with profitability and liabilities. While operational efficiency is improving, technical indicators are bearish, and valuation metrics are unattractive due to negative earnings. The company’s strong liquidity and strategic focus on growth could improve future prospects, but current market conditions and revenue headwinds pose risks.

To see Spark’s full report on TSE:QIPT stock, click here.

More about Quipt Home Medical

Quipt Home Medical Corp. is a U.S.-based provider of home medical equipment, focusing primarily on end-to-end respiratory care. The company operates in the healthcare industry, with a market focus on delivering respiratory solutions and expanding its national footprint through strategic initiatives.

Average Trading Volume: 13,879

Technical Sentiment Signal: Sell

Current Market Cap: C$130.1M

For a thorough assessment of QIPT stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App